ADENOSINE A3 RECEPTOR AGONISTS FOR THE TREATMENT OF DRY EYE DISORDERS INCLUDING SJOGREN'S SYNDROME

摘要

A method for treating and/or preventing Sjogren syndrome, comprising administrating to the individual an A3 adenosine receptor agonist (A3RAg). The A3RAg may be administered either topically or orally.